Skip to main content
Log in

Cost: the new factor clinical cancer investigators must learn to consider

  • Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Antman K, Schnipper LE, Frei E (1988) The crisis in clinical cancer research; third-party insurance and investigational therapy. N Engl J Med 319:46–48

    PubMed  Google Scholar 

  • Laetz T, Silberman G (1991) Reimbursement policies constrain the practice of oncology. JAMA 266:2996–2999

    PubMed  Google Scholar 

  • Wittes RE (1987) Paying for patient care in treatment research; who is responsible? Cancer Treat Rep 71:107–113

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author The Editors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M. Cost: the new factor clinical cancer investigators must learn to consider. J Cancer Res Clin Oncol 119, 263–264 (1993). https://doi.org/10.1007/BF01212723

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01212723

Navigation